Effects of ??-Blockers on Neurohormonal Activation in Patients with Congestive Heart Failure
- 1 November 2000
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 60 (5) , 997-1016
- https://doi.org/10.2165/00003495-200060050-00003
Abstract
The effect of β-adrenoceptor antagonists (β-blockers) on neurohormonal activation in patients with congestive heart failure has been the subject of study in numerous small clinical trials. Short term...Keywords
This publication has 82 references indexed in Scilit:
- The effects of norepinephrine on myocardial biology: Implications for the therapy of heart failureClinical Cardiology, 1998
- The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart FailureNew England Journal of Medicine, 1996
- A sustained increase in β-adrenoceptors during long-term therapy with metoprolol and bisoprolol in patients with heart failure from idiopathic dilated cardiomyopathyLife Sciences, 1996
- Changes in plasma endothelin-1 levels reflect clinical response to β-blockade in chronic heart failureAmerican Heart Journal, 1996
- Early reduction of neurohumoral factors plays a key role in mediating the efficacy of β-blocker therapy for congestive heart failureAmerican Heart Journal, 1996
- Carvedilol improves left ventricular function and symptoms in chronic heart failure: A double-blind randomized studyJournal of the American College of Cardiology, 1995
- Angiotensin-converting enzyme inhibition in congestive heart failure: Benefit and perspectiveAmerican Heart Journal, 1993
- Effect of metoprolol on the β-adrenoceptor density of lymphocytes in patients with dilated cardiomyopathyAmerican Heart Journal, 1993
- Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart FailureNew England Journal of Medicine, 1984
- Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human HeartsNew England Journal of Medicine, 1982